-
Epiprobe completed nearly RMB 100 million of Se...
In recent, Shanghai Epiprobe Biotechnology Co., Ltd. (refer as "Epiprobe") announced that it had completed nearly RMB 100 million in Series B financing, which is jointly invested by industrial capital, government investment platfor...Read more
